Chapter 4 genomics, transcriptomics, and epigenomics in traumatic brain injury research.

Area of Science:

• Neuroscience
• Genetics
• Genomics

Background:

• Traumatic brain injury (TBI) has significant long-term effects, yet effective treatments remain limited.
• TBI's heterogeneity and variable recovery complicate therapeutic development.
• Personalized medicine holds promise for improving TBI survivor outcomes.

Purpose of the Study:

• To review the current state of genomic, transcriptomic, and epigenomic research in TBI.
• To highlight the potential of omics data in understanding TBI recovery.
• To identify future research directions for TBI therapeutics.

Main Methods:

• Review of current scientific literature on TBI genomics, transcriptomics, and epigenomics.
• Analysis of preclinical and clinical studies.
• Synthesis of findings related to omics profiles and TBI recovery.

Main Results:

• Advancements in understanding TBI's molecular underpinnings through omics research.
• Evidence suggests omics data can illuminate TBI recovery variability.
• Much current research remains in the preclinical stage.

Conclusions:

• Genomic, transcriptomic, and epigenomic research provides a foundation for personalized TBI care.
• Further study is needed to translate preclinical findings into clinical applications.
• Omics-based approaches are crucial for improving TBI survivor outcomes.